The Bio Report

Building Better and More Affordable Vaccines

11.01.2023 - By Levine Media GroupPlay

Download our free app to listen on your phone

Download on the App StoreGet it on Google Play

Thomas Rademacher, co-founder and CEO of Emergex Vaccines, discusses the company’s platform technologies, the manufacturing advantages they offer, and its pursuit of universal coronavirus and influenza vaccines that work across variants.

More episodes from The Bio Report